−945 KRW
−42.32 B KRW
100.00 M KRW
39.73 M
About BRIDGE BIOTHERAPEUTICS, INC.
Sector
CEO
Jeong-Gyu Lee
Headquarters
Seongnam-si
Website
Founded
2015
ISIN
KR7288330004
FIGI
BBG00QQCTD07
Bridge Biotherapeutics, Inc. is engaged in the manufacturing of pharmaceutical products. It also engages in the provision pharmacy research, development and experiment of medicines. The company was founded by Jeong-Gyu, Lee on September 17, 2015 and is headquartered in Seongnam-si, South Korea.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 288330 is 3,940 KRW — it has decreased by −2.96% in the past 24 hours. Watch BRIDGE BIOTHERAPEUTICS, INC. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange BRIDGE BIOTHERAPEUTICS, INC. stocks are traded under the ticker 288330.
288330 stock has risen by 27.10% compared to the previous week, the month change is a 38.49% rise, over the last year BRIDGE BIOTHERAPEUTICS, INC. has showed a 89.66% increase.
288330 reached its all-time high on Jan 20, 2020 with the price of 15,715 KRW, and its all-time low was 1,450 KRW and was reached on May 24, 2024. View more price dynamics on 288330 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
288330 stock is 11.56% volatile and has beta coefficient of 0.37. Track BRIDGE BIOTHERAPEUTICS, INC. stock price on the chart and check out the list of the most volatile stocks — is BRIDGE BIOTHERAPEUTICS, INC. there?
Today BRIDGE BIOTHERAPEUTICS, INC. has the market capitalization of 198.62 B, it has increased by 63.80% over the last week.
Yes, you can track BRIDGE BIOTHERAPEUTICS, INC. financials in yearly and quarterly reports right on TradingView.
288330 net income for the last quarter is −4.55 B KRW, while the quarter before that showed −5.70 B KRW of net income which accounts for 20.30% change. Track more BRIDGE BIOTHERAPEUTICS, INC. financial stats to get the full picture.
No, 288330 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 21, 2024, the company has 42.00 employees. See our rating of the largest employees — is BRIDGE BIOTHERAPEUTICS, INC. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BRIDGE BIOTHERAPEUTICS, INC. EBITDA is −27.24 B KRW, and current EBITDA margin is −41.36 K%. See more stats in BRIDGE BIOTHERAPEUTICS, INC. financial statements.
Like other stocks, 288330 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BRIDGE BIOTHERAPEUTICS, INC. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BRIDGE BIOTHERAPEUTICS, INC. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BRIDGE BIOTHERAPEUTICS, INC. stock shows the neutral signal. See more of BRIDGE BIOTHERAPEUTICS, INC. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.